Tenon Medical(R) Announces FDA 510(k) Clearance for SImmetry(R)+ SI Joint Fusion System

October 21, 2025 8:30 AM

Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorders, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the SImmetry+ SI Joint Fusion System. The SImmetry+ System is indicated for sacroiliac (SI) joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis, providing...

Read more

VSee Health (Nasdaq:VSEE) Secures Game-Changing 10M+ Teleradiology Contract, Igniting Explosive Growth in Booming Telehealth Sector

October 21, 2025 8:09 AM

VSee Health, Inc. (Nasdaq:VSEE), a trailblazing leader in telehealth innovation, is thrilled to announce a monumental multi-year teleradiology contract that catapults the Company into a new era of unprecedented growth and shareholder value creation. Executed on May 7, 2025, with service delivery underway since June 15, 2025, this landmark deal with a premier Level 1 hospital system is set to double VSee's annual recurring revenue and unlock a...

Read more

Dr. Angela Fisher's Invitation to Reimagine Love at Cannadelic Global

October 21, 2025 8:00 AM

Ahead of her headline keynote at the Cannadelic Global Summit, Dr. Angela Fisher is calling on seekers, clinicians, couples, and skeptics alike to explore one question: What if love is not a feeling, but a frequency we can return to - on purpose?Her talk, "From Blushing to Bonding," will guide the audience through the erotic neurobiology of connection - a live demonstration of how safety, tension, and intimacy actually work inside the body.This...

Read more

Investors at a Crossroads: Remote Monitoring, Wellness Apps, and Oversold Health IT Categories Face a 2025 Funding Recession as ROI Fatigue Sets In

October 21, 2025 8:00 AM

According to a new Black Book Research pre-HLTH25 survey of 77 institutional and strategic investors controlling $22 billion in deployable capital, the digital health market is entering a correction phase as capital shifts from consumer-facing apps and devices to AI-driven operational platforms with measurable ROI.Capital Rotation AcceleratesThe survey reveals an unmistakable rotation:69% of investors are reducing or exiting hardware-dependent...

Read more

CellRight Technologies, LLC Announces Update and Senior Leadership Changes

October 21, 2025 7:50 AM

CellRight Technologies, LLC, a specialist in regenerative osteoinductive bone scaffolds for patient implants, announces the following organisational changes, whilst remaining focussed on restoring Group revenue growth and profitability, and driving sustainable, long-term growth.Jay LeCoque, newly appointed Executive Chairman of Tissue Regenix, has been appointed acting CEO and Executive Chairman, replacing Daniel Lee as Chief Executive Officer,...

Read more

Telomir Pharmaceuticals Executes Binding LOI for Worldwide Rights to Telomir-1, Positioning the Company for Global Market Expansion and Value Growth

October 21, 2025 7:30 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a preclinical-stage biotechnology company developing therapies that target epigenetic drivers of cancer, aging, and age-related disease, today announced that it has executed a binding Letter of Intent (the "LOI") to acquire TELI Pharmaceuticals, Inc., securing worldwide rights to its lead investigational therapy, Telomir-1.The transaction aligns Telomir's U.S. rights with...

Read more

CBD Life Sciences Inc. (CBDL) Launches First-of-Its-Kind Mushroom-Infused "Dubai Chocolate Bar"

October 21, 2025 7:00 AM

CBD Life Sciences Inc. (OTC PINK:CBDL), through its wholly owned subsidiary CBD Vault, is proud to announce the official launch of its Mushroom-Infused Dubai Chocolate Bar, a premium fusion of functional wellness and luxury indulgence.Inspired by the decadent chocolate culture of Dubai, each bar combines pistachio-filled layers with rich, velvety chocolate and is infused with Cordyceps and Reishi mushroom extracts, two of the most powerful...

Read more

Neutec Group Guides Buyers From Product Discovery to Product Validation With Bioz Badges

October 21, 2025 4:00 AM

Bioz, Inc., a pioneering AI platform changing the way companies present research-backed product evidence, is proud to announce a new partnership with Neutec Group. With the addition of Bioz Badges on their product webpages, and an innovative placement of Bioz Micro Badges within the website's navigation menu, Neutec is setting a new standard in delivering instant scientific proof to their customers.At the heart of this integration is Neutec's...

Read more

BioNxt Launches 15-day Sublingual Cladribine Dosing Optimization Study in Preparation for Human Bioequivalence Study

October 21, 2025 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in next-generation drug delivery technologies, is pleased to announce the launch of an important large-mass animal bioequivalence study for its lead product, BNT23001, a proprietary sublingual Cladribine formulation for the treatment of multiple sclerosis ("MS"). This is the final animal study to generate dosing parameters for...

Read more

Only 27% of European Hospitals Achieve Full Patient Data Exchange Across Borders Despite EU Interoperability Mandates

October 21, 2025 3:00 AM

As Europe advances toward the European Health Data Space (EHDS), a new Black Book Research regional pulse survey exposes persistent interoperability barriers stalling seamless cross-border data exchange.While interoperability readiness has improved by nine percentage points since 2023, a fraction of European hospitals report achieving full cross-border data liquidity , meaning structured, standards-based patient information can flow freely...

Read more

The Piazza Center in Austin Offers New AlloClae Treatment

October 20, 2025 2:00 PM

The Piazza Center for Plastic Surgery & Advanced Skin Care is among the first in the Austin area to offer AlloClae, an innovative, FDA-compliant injectable fat filler revolutionizing non-surgical enhancements for hips, breasts, and buttocks. This cutting-edge treatment provides a minimally invasive solution for patients seeking natural-looking volume restoration without the complexities of traditional surgery.AlloClae, is an innovative...

Read more

U.S. Olympic Athlete Ashley Hoffman Becomes Sam Brand Ambassador for Active Living With Knee Osteoarthritis

October 20, 2025 9:00 AM

Olympic athletes need the most advanced methods to perform at the highest level of sport and to recover from workouts and injuries. After competing in field hockey at the 2024 Paris Olympic Games, Ashley Hoffman turned to the sam® wearable ultrasound unit from ZetrOZ Systems to manage her knee osteoarthritis.As the latest sam® brand ambassador, Hoffman is sharing how the wearable ultrasound device helps with her knee problems."I really like to...

Read more

NEW SURVEY: Four in Five Americans Support Reforms to the Patent System to Lower Drug Prices

October 20, 2025 9:00 AM

The Initiative for Medicines, Access and Knowledge (I-MAK) released findings from a comprehensive survey of 726 American adults examining public attitudes toward prescription drug pricing and potential reforms. Conducted by Franklin & Marshall College's Center for Opinion Research in June 2025, the survey reveals unprecedented bipartisan consensus on the urgent need for prescription drug reform, with patent reform emerging as the most...

Read more

A Measles Drug with Strong Activity without Toxicity Can Be Available Now for Emergency Use, Says NanoViricides - NV-387 Broad-Spectrum Antiviral with Activity Against Measles Virus

October 20, 2025 8:45 AM

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), announced that its clinical lead drug NV-387 has shown strong activity against the Measles virus in a humanized animal model. The Company announces that NV-387 can now be made available for emergency use application in Measles patients to respond to the spreading Measles outbreaks.Having a drug to treat patients has become of paramount importance, in view of the...

Read more

Med-X to Exhibit its Nature-Cide Division at the PestWorld Conference in Orlando from October 21-24, 2025

October 20, 2025 8:31 AM

Med-X, Inc., a leading innovator of all-natural green scene solutions addressing the pest control, health and wellness markets, today announced its participation at PestWorld 2025, scheduled October 21-24 at the Marriott Orlando World Center in Orlando, Florida. Med-X's leadership team will present the full Nature-Cide product portfolio to pest management professionals, distributors, and industry leaders and stakeholders. Each year, the...

Read more

Stemtech Corporation Backorders Filled

October 20, 2025 8:30 AM

Stemtech Corporation, the global leader and pioneer in stem cell nutrition, announces core products are available for shipment after overcoming challenges with supply delivery and manufacturing. Stemtech Corporation, a Nevada USA company (OTCQB:STEK).Stemtech Corporation Chairman & CEO, Charles S. Arnold, states "having inventory to fill orders after dealing with supply issues related to tariffs and capital constraints for some of our...

Read more

Health Impact Alliance and Connect America Announce "LifelineConnect" to Transform Senior Independence

October 20, 2025 8:00 AM

Health Impact Alliance (HIA) and Connect America today announced a Letter of Intent under which Connect America will grant HIA rights to expand the iconic Lifeline brand across North America, subject to a definitive agreement. The partnership combines Lifeline's 50-year legacy of trusted emergency response with HIA's innovative connected healthcare ecosystem to support senior independence at scale.Under the new brand LifelineConnect, the...

Read more

Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline

October 20, 2025 7:45 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company focused on innovative and affordable healthcare solutions, today announced the commercial launch of generic Doxycycline in Canada. This strategic move strengthens the Company's footprint in the Canadian growing antibiotic sector. Doxycycline is now available to pharmacies, hospitals and healthcare providers nationwide.Doxycycline is a broad-spectrum...

Read more

HLTH 2025: 150 Past Attendees and Investors Identify Their Five AI Platform Categories Set to Displace Legacy Health IT in 2026

October 20, 2025 7:30 AM

Investor attention at HLTH 2025 is consolidating around a focused set of AI platform categories expected to drive the next phase of health IT disruption. Black Book Research surveyed 154 past HLTH attendees and healthcare investors including those with both successful and failed investments using an investor-specific KPI framework to analyze which AI innovations are most likely to outperform in performance, delivery, and displacement...

Read more

Peer-Reviewed Journal of Clinical Psychiatry Publishes Mentavi's Online ADHD Diagnostic Evaluation Validation Study

October 20, 2025 6:00 AM

Mentavi Health announced that its landmark, real-world validation study of the Mentavi Diagnostic Evaluation has been published in the peer reviewed Journal of Clinical Psychiatry (JCP). In what is believed to be the first peer-reviewed study of its kind, an asynchronous, online evaluation matched the diagnostic accuracy of a clinician-led interview for adult ADHD. This publication provides the first peer-reviewed evidence base for a fully...

Read more